Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
February 25, 2026

[vc_row][vc_column][vc_single_image image="67187" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Researchers have found a promising biomarker that may help doctors predict which patients with extensive-stage small cell lung cancer (ES-SCLC) are most likely to respond to tarlatamab. This targeted immunotherapy is possible because of new insights into DLL3 biology, partially...

, , , ,

by
Blog
February 17, 2026

[vc_row][vc_column][vc_empty_space][vc_raw_html css=""]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[/vc_raw_html][vc_empty_space height="22px"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] What does it look like when scientific discovery moves beyond the lab and changes the course of entire communities? In the latest episode of All Things Cancer, Dr. Sujuan Ba speaks with physician-scientist Dr. Michele Carbone about a journey that began in small...

, , , , ,

by
Blog
April 14, 2025

[vc_row][vc_column][vc_single_image image="63691" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] A new treatment may soon bring relief to people suffering from pulmonary sarcoidosis, a serious lung disease with few good treatment options. The discovery comes from research led by Dr. Paul Schimmel of Scripps Research, a longtime scientist supported by...

, ,

by
Blog
September 20, 2021

[vc_row][vc_column][vc_single_image image="44750" img_size="full" alignment="center"][vc_column_text]Immune checkpoint inhibitor (ICI) drugs, such as the PD-1inhibitors nivolumab and pembrolizumab, have provided unprecedented survival to patients in many types of cancer in recent years and are used for late-stage cancer treatment worldwide. Unfortunately, many patients who responded well to initial treatments gradually...

, , , ,

by
Blog
July 18, 2021

[vc_row][vc_column][vc_single_image image="43870" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Lung Cancer is the deadliest type of cancer in the US. The American Cancer Society estimates that about 132,000 people will die of the disease in 2021. Thanks to the constant progress of innovative research and new drug development, mortality...

,

by
Blog, Cancer-Fighting Lifestyle
January 16, 2020

[vc_row][vc_column][vc_single_image image="31015" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]When it hit the market in 2004, vaping (e-cigarettes) was marketed as a hip, sexy, and even healthier alternative to smoking. Millennials, just coming of age, took the bait and ran with it; one study of the youth population shows...

,